Empagliflozin in Heart Failure with a Preserved Ejection Fraction - Anker, Stefan D; Butler, Javed; Filippatos, Gerasimos; Ferreira, João P; Bocchi, Edimar; Böhm, Michael; Brunner–La Rocca, Hans-Peter; Choi, Dong-Ju; Chopra, Vijay; Chuquiure-Valenzuela, Eduardo; Giannetti, Nadia; Gomez-Mesa, Juan Esteban; et al. (The New England journal of medicine, 2021)
Keywords: Adult; Antidiabetics; Benzhydryl Compounds - administration & dosage; Benzhydryl Compounds - adverse effects; Cardiology; Cardiology and cardiovascular system; Cardiology General; Cardiovascular diseases; Cardiovascular Diseases - mortality; Cardiovascular Diseases - prevention & control; Chronic Disease; Congestive heart failure; Diabetes; Diabetes mellitus; Double-Blind Method; Ejection fraction; Female; Glucosides - administration & dosage; Glucosides - adverse effects; Heart Failure; Heart Failure - drug therapy; Heart Failure - physiopathology; Hospitalization - statistics & numerical data; Human health and pathology; Humans; Hypotension; Life Sciences; Male; Patient safety; Placebos; Sodium-glucose cotransporter; Sodium-Glucose Transporter 2 Inhibitors - administration & dosage; Sodium-Glucose Transporter 2 Inhibitors - adverse effects; Statistical analysis; Stroke Volume; Urinary tract